Zydus has in-licensed FYB206, a proposed biosimilar to immuno-oncology therapy Keytruda (pembrolizumab), exclusively from Formycon AG for the U.S. and Canadian markets
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
Our portfolio transformation over the past few years positions us well to capitalize on improving end market conditions and deliver differentiated results in the years to come
The Fast Track Designation was supported by nonclinical data as well as clinical results from the ongoing Phase I/IIa trial evaluating the safety and tolerability
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
GE HealthCare’s Revolution Vibe CT enables more facilities to elevate patient care by offering advanced cardiac imaging technology
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Subscribe To Our Newsletter & Stay Updated
